Novo-Nordisk A/S News

Novo Nordisk Analyst Ratings

BenzingaApr 18 09:58 ET

Novo Nordisk Analyst Ratings

BenzingaApr 12 05:13 ET

Novo Nordisk Analyst Ratings

BenzingaApr 5 09:31 ET

Novo Nordisk Analyst Ratings

BenzingaApr 1 08:38 ET

Novo Nordisk Analyst Ratings

BenzingaMar 20 08:54 ET

Novo Nordisk Analyst Ratings

BenzingaMar 8 12:35 ET

Novo Nordisk Analyst Ratings

BenzingaFeb 20 12:42 ET

Novo Nordisk Analyst Ratings

BenzingaFeb 14 11:32 ET

Cantor Fitzgerald Raises Price Target on Novo Nordisk to $140 From $120, Keeps Overweight Rating

MT NewswiresFeb 1 08:19 ET

Novo Nordisk Analyst Ratings

BenzingaJan 23 05:36 ET

Amgen Upgraded at RBC on Catalyst Setup and Growth Drivers

Seeking AlphaDec 12, 2023 11:51 ET

TD Cowen Maintains Outperform on Novo Nordisk, Raises Price Target to $115

BenzingaDec 4, 2023 12:27 ET

Novo Nordisk Analyst Ratings

BenzingaDec 4, 2023 12:25 ET

Cantor Fitzgerald Initiates Coverage On Novo Nordisk With Overweight Rating, Announces Price Target of $120

BenzingaDec 1, 2023 08:49 ET

Novo Nordisk Analyst Ratings

BenzingaDec 1, 2023 08:47 ET

ResMed Upgraded at JPMorgan; Says GLP-1 Threat Overdone

Seeking AlphaOct 9, 2023 15:19 ET

Argus Research Initiates Coverage On Novo Nordisk With Buy Rating, Announces Price Target of $110

BenzingaOct 2, 2023 10:30 ET

Novo Nordisk Analyst Ratings

BenzingaOct 2, 2023 10:28 ET

Berenberg Bank Adjusts Novo Nordisk Price Target to $88 From $177, Maintains Hold Rating

MT NewswiresSep 13, 2023 08:17 ET

Eli Lilly Upgraded at Jefferies on Mounjaro Sales and Wegovy Data

Seeking AlphaAug 9, 2023 09:15 ET